The program "The Universal Definition of MI & Troponin, Clearing the confusion" is intended to review the recently released Third Universal Definition of Myocardial Infarction and aims to familiarize clinicians and laboratory health care providers with the implications for current practice.

The focus will be on understanding the use of troponin in the Clinical Setting and my discussions will include:

• The identification of pathological characteristics of myocardial ischemia and infarction,
• The classification framework created by the 2007 Universal Definition of MI,
• The biomarker preference and endorsement of cardiac troponins as preferred biomarker for each category of MI emphasizing that an increased troponin concentration is defined as a value exceeding the 99th percentile of a normal reference population, and
• The differentiation of acute and chronic cTn elevations.